NASDAQ:ADUS - Addus Homecare Stock Price, Forecast & News

Addus Homecare trades on the NASDAQ under the ticker symbol "ADUS."

Addus Homecare Co. (NASDAQ:ADUS) announced its earnings results on Monday, November, 4th. The company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.49 by $0.13. The firm had revenue of $169.80 million for the quarter, compared to the consensus estimate of $160.25 million. Addus Homecare had a net margin of 3.35% and a return on equity of 8.00%. Addus Homecare's revenue for the quarter was up 23.3% compared to the same quarter last year. View Addus Homecare's Earnings History.

Addus Homecare is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Addus Homecare.

Addus Homecare will be holding an earnings conference call on Thursday, February 27th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

7 brokers have issued twelve-month price objectives for Addus Homecare's stock. Their forecasts range from $85.00 to $115.00. On average, they expect Addus Homecare's share price to reach $99.83 in the next year. This suggests a possible upside of 6.6% from the stock's current price. View Analyst Price Targets for Addus Homecare.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Addus Homecare in the last year. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Addus Homecare.

Media coverage about ADUS stock has been trending very negative this week, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Addus Homecare earned a coverage optimism score of -3.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Addus Homecare.

Some companies that are related to Addus Homecare include BioScrip (BIOS), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), Option Care Health (OPCH) and New York Health Care (BBAL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus Homecare investors own include AbbVie (ABBV), Incyte (INCY), Ulta Beauty (ULTA), Bristol-Myers Squibb (BMY), Humana (HUM), Verizon Communications (VZ), Align Technology (ALGN), Activision Blizzard (ATVI), Cisco Systems (CSCO) and Gilead Sciences (GILD).

Addus Homecare's stock is owned by a number of of institutional and retail investors. Top institutional investors include Eos Management L.P. (6.69%), Principal Financial Group Inc. (2.63%), Standard Life Aberdeen plc (2.46%), State Street Corp (2.41%), Capital World Investors (1.86%) and Eaton Vance Management (1.56%). Company insiders that own Addus Homecare stock include Brian Poff, Darby Anderson, David W Tucker, Eos Capital Partners Iii L P, James Zoccoli, Laurie Manning, Mark L First, R Dirk Allison, Susan T Weaver and W Bradley Bickham. View Institutional Ownership Trends for Addus Homecare.

ADUS stock was sold by a variety of institutional investors in the last quarter, including Eos Management L.P., Point72 Asset Management L.P., Marshall Wace LLP, Royce & Associates LP, Castleark Management LLC, FMR LLC, PNC Financial Services Group Inc. and Chartwell Investment Partners LLC. Company insiders that have sold Addus Homecare company stock in the last year include Brian Poff, Darby Anderson, David W Tucker, James Zoccoli, Laurie Manning, Mark L First, R Dirk Allison, Susan T Weaver and W Bradley Bickham. View Insider Buying and Selling for Addus Homecare.

ADUS stock was purchased by a variety of institutional investors in the last quarter, including Standard Life Aberdeen plc, Redwood Investments LLC, Fort Washington Investment Advisors Inc. OH, Rothschild & Co. Asset Management US Inc., Marshall Wace North America L.P., Capital World Investors, First Trust Advisors LP and State Street Corp. View Insider Buying and Selling for Addus Homecare.

Shares of ADUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ADUS stock can currently be purchased for approximately $93.62.

Addus Homecare has a market capitalization of $1.46 billion and generates $518.12 million in revenue each year. The company earns $17.50 million in net income (profit) each year or $1.69 on an earnings per share basis. Addus Homecare employs 33,153 workers across the globe.View Additional Information About Addus Homecare.

The official website for Addus Homecare is http://www.addus.com/.

Addus Homecare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The company can be reached via phone at 469-535-8200 or via email at [email protected]